Designers and entrepreneurs fashion face masks for medical professionals in Houston

ready and resourceful

A few local designers have pivoted to create face masks for local health care workers. Photo courtesy of Magpies & Peacocks

The coronavirus is sweeping the globe and creating new challenges. Notably, companies are not able to keep up with the demand for the N95 masks needed to keep the health care workers safe. Now, Houston's fashion industry is stepping up.

Megan Eddings, founder of Accel Lifestyle, says an article she read about the Centers for Disease Control and Prevention (CDC) advising health care professionals to wear homemade masks or bandanas due to the shortage of the N95 masks inspired her. She was compelled to help combat the COVID-19 pandemic locally and nationwide.

"Accel's Prema fabric was created to prevent the growth of bacteria," Eddings tells CultureMap. "The fabric can be washed up to 100 times and it will still be 99.99-percent anti-bacteria."

Eddings says it dawned on her that she has over 500 shirts made, here in Houston, that could easily be recreated into masks. Her supply chain team consists of 20 sewers and she notes that number can quickly double.

"We have enough supplies here to make 9,000 masks and I have 2,800 yards of fabric sitting at my factory in California," she says. "That's enough fabric to make more than 100,000 masks."

Eddings and her team also tell CultureMap that 47,000 yards of elastic is en route to the Bayou City this week.

"I knew this was serious when the president of MD Anderson responded to my Saturday morning email within three minutes of sending," she says. "He's interested, and they want the infection control team to analyze the fabric."

Other local hospitals interested in Accel Lifestyle's masks are Methodist, Texas Children's, Baylor, and Memorial Hermann. The Memorial Sloan Kettering Cancer Center in New York City has also shown interest as well as Yale's New Haven Hospital in New Haven, Connecticut.

Accel's masks are made out of their specialty anti-bacteria fabric. Photo courtesy of Accel

When Chloe Dao made the decision to temporarily close her Rice Village boutique last Tuesday, offering shopping requests by appointment only, she posted a video to her Instagram account the following day about the emotional roller coaster she's been on surrounding the COVID-19 outbreak.

In the video, Dao says she wanted to play a role in helping her community by creating a pattern and hand sewing 100 washable face masks with pockets. She noted in the caption that the pocket allows for extra filtration but that because it's a fabric mask, it does not stop the spread of the virus. Dao also recommends washing the mask before wearing it.

With production underway since her initial 100 masks, available in small/medium and medium/large, Dao and her team have produced close to 1,000 masks for Houstonians who reached out via social media.

"The requests are overwhelming," a representative for the label tells CultureMap. "We're now shifting our focus to help those on the front line of the coronavirus outbreak; the doctors, nurses, family members of doctors and nurses."

For those who would like to donate to Dao's efforts to continue producing these washable masks, click here.

Houston-based, internationally recognized nonprofit design house, Magpies & Peacocks, and Inclán Studio, a local women's ready-to-wear fashion label, are upcycling together to create nonwoven polypropylene masks, which will be distributed to Houston-area hospitals.

Founder and CEO, Sarah-Jayne Smith and vice president and director of communications/PR, Ahshia Berry, tells CultureMap that partnering together was never a question for either of our brands but more "how can we pull our resources together and help during these trying times."

Clarence Lee, a designer at Inclán Studio, tells CultureMap he searched the studio to find elastic cording that didn't get used in past collections.

"Waste as a resource and upcycling material for good use has never been more important than it is right now," Magpies & Peacocks writes on an Instagram post.

Houston Arts Alliance and Visit Houston donated excess promotional products and now, are deconstructed to reuse the material for these masks.

"It's actually a spun plastic, not a fabric, so it works effectively as a filter, and is more moisture resistant," Magpies & Peacocks tells CultureMap. "It's more compliant and efficient for the current exposure to the service industry in the midst of the crisis."

Lee, who is also a lead designer for Magpies & Peacocks, and serves as an executive board member for the nation's exclusive nonprofit design house, tells CultureMap that for them, it simply boils down to help in any capacity, especially after seeing what's happening across the country with the shortage of supplies.

He notes that they may not have all the supplies, but they do have the capability and time to sew to help those that are on the frontline, fighting and sacrificing everything they have.

"[Houston] is our home, and we all have a part to play in helping fight this," he says. "The [fashion] industry has a major role, and now is definitely the time to show how valuable it can be."

Magpies & Peacocks and Inclán Studio aim to produce 500-600 masks, and hopefully more, should they come across more materials, Lee tells CultureMap. Seven volunteers are helping to sew these nonwoven polypropylene masks.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

NASA unveils Artemis III astronauts at Johnson Space Center in Houston

To the moon

NASA on Tuesday, June 9, revealed the crew for its Artemis III mission, the next step in the space agency's plan to eventually land astronauts on the moon.

The announcement came two months after Artemis II's record-breaking trip around the moon that surpassed the distance record of Apollo 13.

NASA's Randy Bresnik, Frank Rubio, Andre Douglas and the European Space Agency's Luca Parmitano won't fly to the moon or land on the surface. Instead, they’ll orbit Earth while practicing docking their Orion capsule with two lunar landers.

“To the Artemis III crew, we wish you Godspeed on the journey ahead,” said NASA administrator Jared Isaacman.

Elon Musk’s SpaceX and Jeff Bezos’ Blue Origin are racing to deliver the lunar landers. The two-week demo is targeted for 2027. Blue Origin suffered a recent setback when its massive rocket exploded during an engine-firing test on the launch pad in Florida, shaking nearby homes and illuminating the sky with an orange fireball.

NASA's Jeremy Parsons said the setback is a learning opportunity and that the space agency is confident Blue Origin's rocket will be ready in time.

NASA's Artemis program aims to return astronauts to the moon's surface for the first time since the 1970s. A recent revamp of the program announced by Isaacman aims to fast-track it similarly to the Apollo era, adding the upcoming spaceflight around Earth before eyeing a lunar landing in 2028.

“We are certainly humbled as a crew to be able to be your crew that executes this Artemis III mission in space,” said Bresnik, Artemis III commander.

Added Douglas, mission specialist: “My brain — it is going a mile a minute right now. But my heart, it is so warm. It is so full."

In May, NASA awarded hundreds of millions of dollars in contracts to four companies, including Blue Origin, to build landers, rovers and drones for a future moon base. Isaacman said the goal of the moon base is to lay the foundation for a Mars expedition.

Meta to bring $115 million AI data center training initiative to Houston

ai workforce

Meta and Associated Builders and Contractors have entered into a partnership to invest $115 million in training programs for the construction of AI data centers, with a portion of the project launching in Houston.

The companies announced June 8 that they would open America’s Workforce Academies at ABC chapter training centers in Houston; Indianapolis; Baton Rouge, Louisiana; and Columbus, Ohio.

The academies will offer career readiness and safety training, plus five weeks of hands-on education. Participants who complete the program will be granted a job offer from contractors working on Meta projects.

“The AI revolution is bringing change but also historic opportunities,” Dina Powell McCormick, Meta president and vice-chairman, said in a news release. “Skilled workers electrified rural America one pole at a time. They manned the factories that built the arsenal that won World War II. Now a new generation will pour the foundations and lay the fiber that secures American strength in this new age.”

Overall, the Meta and ABC aim for the academies to build a more sustainable pipeline of skilled construction workers and ensure safety and job readiness for the surging number of data center projects underway.

“This new program is an innovative talent solution that is a critical part of addressing the construction industry’s ongoing workforce shortage and creates an accelerated, new-entrant strategy for job seekers ... The sustained demand for data center construction technicians means the industry needs an all-of-the-above approach to address this shortage and grow the construction talent pool,” Michael Bellaman, ABC president and CEO, added in the release.

In Texas, Meta, the parent company of Facebook and Instagram, has launched or broken ground on data centers in El Paso, Fort Worth and Temple. The company announced in March that it planned to grow its El Paso Data center by 1 gigawatt, representing more than a $10 billion investment.

Apart from Meta, Texas has attracted data center development to power other giants like Google and Amazon in recent years. In turn, Texas has been predicted to become the biggest data center market. Commercial real estate services provider JLL reported this spring that the state could topple Northern Virginia as the world’s largest data-center market by 2030. Similarly, CBRE predicted that Houston's data center capacity could double by 2028. Read more here.

New Houston biotech co. lands $30M for pulmonary fibrosis drug

drug money

Most of us can claim a scar or two on our bodies. But when scarring develops inside the body, it’s known as a fibrotic disorder. A freshly launched Houston company, Oorja Bio Inc., is working on a treatment that can help to repair cells and reduce the damage wrought by the growth of fibrotic tissue in patients.

Late last month, Oorja Bio hit the scene with a pair of big announcements. Not only has the company raised a $30 million Series A thanks to founding investor California-based Westlake BioPartners, but it has also already paved the way for a Phase 2 study to take place this year.

Oorja Bio received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to test its treatment in patients with idiopathic pulmonary fibrosis (IPF), a scarring of the lung tissue. IPF affects more than 150,000 adults in the United States and can result in a range of symptoms from shortness of breath to organ failure and death as it progresses.

Oorja Bio’s lead drug candidate, ORJ-001, was shown in a Phase 1 in-human trial to demonstrate “therapeutically relevant exposure and favorable tolerability” in 64 healthy adult volunteers in whom it was administered daily or weekly, according to a news release. Pre-clinical studies of ORJ-001 showed durable target tissue engagement and biomarker activity in bleomycin-induced lung fibrosis.

Administered subcutaneously, ORJ-001 is intended to improve and even restore function in cells that can reduce the signaling that causes IPF. It stops advancement of IPF and also allows for tissue repair. Currently available treatments for the disease can slow the development of IPF down, but do not address the declining lung function that’s inherent in its progression.

“The clinical and preclinical results from our studies to date give us confidence that ORJ-001 represents a novel treatment approach with the potential to repair and reverse fibrosis and modify disease progression in IPF,” Dr. Janethe Pena, CMO of Oorja Bio, said in the release.

“Our team is energized to deliver on our goal of redefining the future of fibrotic diseases, beginning with ORJ-001,” CEO and founder Sujay Kango added. “As we advance ORJ-001 in the clinic, we are embracing the paradigm shift in our biological understanding of IPF pathology that aligns with the central role of the alveolar epithelium. ORJ-001 was designed with this biology in mind and may provide, for the first time, a therapeutic intervention that repairs and reverses fibrosis and promotes disease modification.”

Most patients live only three to five years following their IPF diagnosis. Soon, ORJ-001 and Oorja Bio could give them a fighting chance.

View All Listings